{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:51:01Z","timestamp":1740163861394,"version":"3.37.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Spanish National Health Institute","award":["CP17\/00206-EU-FEDER"],"award-info":[{"award-number":["CP17\/00206-EU-FEDER"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The influence of socioeconomic status (SES) on access to standard chemotherapy and\/or monoclonal antibody therapy, and associated secular trends, relative survival, and excess mortality, among diffuse large B-cell lymphoma (DLBCL) patients is not clear. We conducted a Hong Kong population-based cohort study and identified adult patients with histologically diagnosed DLBCL between 2000 and 2018. We examined the association of SES levels with the odds and the secular trends of receipt of chemotherapy and\/or rituximab. Additionally, we estimated the long-term relative survival by SES utilizing Hong Kong life tables. Among 4017 patients with DLBCL, 2363 (58.8%) patients received both chemotherapy and rituximab and 740 (18.4%) patients received chemotherapy alone, while 1612 (40.1%) and 914 (22.8%) patients received no rituximab or chemotherapy, respectively. On multivariable analysis, low SES was associated with lesser use of chemotherapy (odd ratio [OR] 0.44; 95% CI 0.34\u20130.57) and rituximab (OR 0.41; 95% CI 0.32\u20130.52). The socioeconomic disparity for either treatment showed no secular trend of change. Additionally, patients with low SES showed increased excess mortality, with a hazard ratio of 2.34 (95% CI 1.67\u20133.28). Improving survival outcomes for patients with DLBCL requires provision of best available medical care and securing access to treatment regardless of patients\u2019 SES.<\/jats:p>","DOI":"10.1038\/s41598-021-97455-5","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T10:06:24Z","timestamp":1631181984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Socioeconomic inequalities in treatment and relative survival among patients with diffuse large B-cell lymphoma: a Hong Kong population-based study"],"prefix":"10.1038","volume":"11","author":[{"given":"Shing Fung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Evens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-5164","authenticated-orcid":false,"given":"Miguel-Angel","family":"Luque-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"97455_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras, L. R. et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J. Clin. 66, 443\u2013459. https:\/\/doi.org\/10.3322\/caac.21357 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"97455_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","volume":"50","author":"S Li","year":"2018","unstructured":"Li, S., Young, K. H. & Medeiros, L. J. Diffuse large B-cell lymphoma. Pathology 50, 74\u201387. https:\/\/doi.org\/10.1016\/j.pathol.2017.09.006 (2018).","journal-title":"Pathology"},{"key":"97455_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"97455_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","volume":"30","author":"A Miranda-Filho","year":"2019","unstructured":"Miranda-Filho, A. et al. Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes Control 30, 489\u2013499. https:\/\/doi.org\/10.1007\/s10552-019-01155-5 (2019).","journal-title":"Cancer Causes Control"},{"key":"97455_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3322\/caac.20087","volume":"60","author":"CR Flowers","year":"2010","unstructured":"Flowers, C. R., Sinha, R. & Vose, J. M. Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J. Clin. 60, 393\u2013408. https:\/\/doi.org\/10.3322\/caac.20087 (2010).","journal-title":"CA Cancer J. Clin."},{"key":"97455_CR6","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin's Lymphoma (version 3.2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf. Accessed on April 1, 2021."},{"key":"97455_CR7","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1055-9965.Epi-12-0466","volume":"21","author":"CR Flowers","year":"2012","unstructured":"Flowers, C. R. et al. Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol. Biomark. Prev. 21, 1520\u20131530. https:\/\/doi.org\/10.1158\/1055-9965.Epi-12-0466 (2012).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"97455_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.canep.2017.04.009","volume":"48","author":"K Boslooper","year":"2017","unstructured":"Boslooper, K. et al. No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status. Cancer Epidemiol. 48, 110\u2013116. https:\/\/doi.org\/10.1016\/j.canep.2017.04.009 (2017).","journal-title":"Cancer Epidemiol."},{"key":"97455_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/bmj.321.7260.563","volume":"321","author":"Y Doyle","year":"2000","unstructured":"Doyle, Y. & Bull, A. Role of private sector in United Kingdom healthcare system. BMJ 321, 563\u2013565. https:\/\/doi.org\/10.1136\/bmj.321.7260.563 (2000).","journal-title":"BMJ"},{"key":"97455_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1744-8603-7-12","volume":"7","author":"NS Pocock","year":"2011","unstructured":"Pocock, N. S. & Phua, K. H. Medical tourism and policy implications for health systems: A conceptual framework from a comparative study of Thailand, Singapore and Malaysia. Glob. Health 7, 12. https:\/\/doi.org\/10.1186\/1744-8603-7-12 (2011).","journal-title":"Glob. Health"},{"key":"97455_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557 (2003).","journal-title":"BMJ"},{"key":"97455_CR12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.12809\/hkmj133793","volume":"19","author":"OF Wong","year":"2013","unstructured":"Wong, O. F., Ho, P. L. & Lam, S. K. Retrospective review of clinical presentations, microbiology, and outcomes of patients with psoas abscess. Hong Kong Med. J. 19, 416\u2013423. https:\/\/doi.org\/10.12809\/hkmj133793 (2013).","journal-title":"Hong Kong Med. J."},{"key":"97455_CR13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","volume":"149","author":"EW Chan","year":"2015","unstructured":"Chan, E. W. et al. Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: A population-based study. Gastroenterology 149, 586-595.e583. https:\/\/doi.org\/10.1053\/j.gastro.2015.05.002 (2015).","journal-title":"Gastroenterology"},{"key":"97455_CR14","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa020546","volume":"347","author":"SS Chiu","year":"2002","unstructured":"Chiu, S. S., Lau, Y. L., Chan, K. H., Wong, W. H. & Peiris, J. S. Influenza-related hospitalizations among children in Hong Kong. N. Engl. J. Med. 347, 2097\u20132103. https:\/\/doi.org\/10.1056\/NEJMoa020546 (2002).","journal-title":"N. Engl. J. Med."},{"key":"97455_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2017.43","volume":"8","author":"KS Cheung","year":"2017","unstructured":"Cheung, K. S., Seto, W. K., Fung, J., Lai, C. L. & Yuen, M. F. Epidemiology and natural history of primary biliary cholangitis in the Chinese: A territory-based study in Hong Kong between 2000 and 2015. Clin. Transl. Gastroenterol. 8, e116. https:\/\/doi.org\/10.1038\/ctg.2017.43 (2017).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"97455_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c332","author":"KF Schulz","year":"2010","unstructured":"Schulz, K. F., Altman, D. G. & Moher, D. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMJ https:\/\/doi.org\/10.1136\/bmj.c332 (2010).","journal-title":"BMJ"},{"key":"97455_CR17","doi-asserted-by":"publisher","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N. Engl. J. Med. 329, 987\u2013994. https:\/\/doi.org\/10.1056\/nejm199309303291402 (1993).","DOI":"10.1056\/nejm199309303291402"},{"key":"97455_CR18","unstructured":"Social Welfare Department, The Government of the Hong Kong Special Administrative Region. Comprehensive Social Security Assistance (CSSA) Scheme. https:\/\/www.swd.gov.hk\/en\/index\/site_pubsvc\/page_socsecu\/sub_comprehens\/. (2020). Accessed on April 1, 2021."},{"key":"97455_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3414\/me17-01-0051","volume":"56","author":"N Brusselaers","year":"2017","unstructured":"Brusselaers, N. & Lagergren, J. The Charlson Comorbidity Index in registry-based research. Methods Inf. Med. 56, 401\u2013406. https:\/\/doi.org\/10.3414\/me17-01-0051 (2017).","journal-title":"Methods Inf. Med."},{"key":"97455_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/bjs.6930","volume":"97","author":"JN Armitage","year":"2010","unstructured":"Armitage, J. N. & van der Meulen, J. H. Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score. Br. J. Surg. 97, 772\u2013781. https:\/\/doi.org\/10.1002\/bjs.6930 (2010).","journal-title":"Br. J. Surg."},{"key":"97455_CR21","volume-title":"Foundations of Linear and Generalized Linear Models","author":"A Agresti","year":"2015","unstructured":"Agresti, A. Foundations of Linear and Generalized Linear Models (Wiley, 2015)."},{"key":"97455_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins, J. M., Hernan, M. A. & Brumback, B. Marginal structural models and causal inference in epidemiology. Epidemiology 11, 550\u2013560 (2000).","journal-title":"Epidemiology"},{"key":"97455_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/ndt\/gfw341","volume":"32","author":"T Williamson","year":"2017","unstructured":"Williamson, T. & Ravani, P. Marginal structural models in clinical research: When and how to use them?. Nephrol. Dial. Transplant. 32, 84\u201390. https:\/\/doi.org\/10.1093\/ndt\/gfw341 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"key":"97455_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/332083a0","volume":"332","author":"M Kawano","year":"1988","unstructured":"Kawano, M. et al. Autocrine generation and requirement of BSF-2\/IL-6 for human multiple myelomas. Nature 332, 83\u201385. https:\/\/doi.org\/10.1038\/332083a0 (1988).","journal-title":"Nature"},{"key":"97455_CR25","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1182\/blood-2013-07-517110","volume":"123","author":"L Tao","year":"2014","unstructured":"Tao, L., Foran, J. M., Clarke, C. A., Gomez, S. L. & Keegan, T. H. Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era. Blood 123, 3553\u20133562. https:\/\/doi.org\/10.1182\/blood-2013-07-517110 (2014).","journal-title":"Blood"},{"key":"97455_CR26","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1002\/cncr.23914","volume":"113","author":"M Wang","year":"2008","unstructured":"Wang, M., Burau, K. D., Fang, S., Wang, H. & Du, X. L. Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer 113, 3231\u20133241. https:\/\/doi.org\/10.1002\/cncr.23914 (2008).","journal-title":"Cancer"},{"key":"97455_CR27","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/cncr.28549","volume":"120","author":"X Han","year":"2014","unstructured":"Han, X. et al. Insurance status is related to diffuse large B-cell lymphoma survival. Cancer 120, 1220\u20131227. https:\/\/doi.org\/10.1002\/cncr.28549 (2014).","journal-title":"Cancer"},{"key":"97455_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.canep.2015.08.015","volume":"39","author":"A Smith","year":"2015","unstructured":"Smith, A. et al. Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: A UK population-based study of diffuse large B-cell lymphoma. Cancer Epidemiol. 39, 1103\u20131112. https:\/\/doi.org\/10.1016\/j.canep.2015.08.015 (2015).","journal-title":"Cancer Epidemiol."},{"key":"97455_CR29","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ejca.2010.11.014","volume":"47","author":"BL Frederiksen","year":"2011","unstructured":"Frederiksen, B. L., Brown Pde, N., Dalton, S. O., Steding-Jessen, M. & Osler, M. Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: Analysis of a national clinical database. Eur. J. Cancer (Oxford Engl. 1990) 47, 910\u2013917. https:\/\/doi.org\/10.1016\/j.ejca.2010.11.014 (2011).","journal-title":"Eur. J. Cancer (Oxford Engl. 1990)"},{"key":"97455_CR30","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/bjc.2012.3","volume":"106","author":"BL Frederiksen","year":"2012","unstructured":"Frederiksen, B. L., Dalton, S. O., Osler, M., Steding-Jessen, M. & de Nully Brown, P. Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark\u2014A nationwide study. Br. J. Cancer 106, 988\u2013995. https:\/\/doi.org\/10.1038\/bjc.2012.3 (2012).","journal-title":"Br. J. Cancer"},{"key":"97455_CR31","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1002\/cncr.25427","volume":"116","author":"CM Booth","year":"2010","unstructured":"Booth, C. M., Li, G., Zhang-Salomons, J. & Mackillop, W. J. The impact of socioeconomic status on stage of cancer at diagnosis and survival: A population-based study in Ontario, Canada. Cancer 116, 4160\u20134167. https:\/\/doi.org\/10.1002\/cncr.25427 (2010).","journal-title":"Cancer"},{"key":"97455_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1634\/theoncologist.2013-0343","volume":"19","author":"B Lee","year":"2014","unstructured":"Lee, B. et al. Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia. Oncologist 19, 283\u2013290. https:\/\/doi.org\/10.1634\/theoncologist.2013-0343 (2014).","journal-title":"Oncologist"},{"key":"97455_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/eurpub\/ckv233","volume":"26","author":"M Orsini","year":"2016","unstructured":"Orsini, M., Tr\u00e9tarre, B., Daur\u00e8s, J.-P. & Bessaoud, F. Individual socioeconomic status and breast cancer diagnostic stages: A French case\u2013control study. Eur. J. Public Health 26, 445\u2013450. https:\/\/doi.org\/10.1093\/eurpub\/ckv233 (2016).","journal-title":"Eur. J. Public Health"},{"key":"97455_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/jech.55.2.111","volume":"55","author":"KE Pickett","year":"2001","unstructured":"Pickett, K. E. & Pearl, M. Multilevel analyses of neighbourhood socioeconomic context and health outcomes: A critical review. J. Epidemiol. Community Health 55, 111\u2013122. https:\/\/doi.org\/10.1136\/jech.55.2.111 (2001).","journal-title":"J. Epidemiol. Community Health"},{"key":"97455_CR35","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s11524-016-0085-2","volume":"93","author":"M Hussein","year":"2016","unstructured":"Hussein, M., Diez Roux, A. V. & Field, R. I. Neighborhood socioeconomic status and primary health care: Usual points of access and temporal trends in a major US urban area. J. Urban Health 93, 1027\u20131045. https:\/\/doi.org\/10.1007\/s11524-016-0085-2 (2016).","journal-title":"J. Urban Health"},{"key":"97455_CR36","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/sj.bjc.6605949","volume":"103","author":"WJ Louwman","year":"2010","unstructured":"Louwman, W. J. et al. A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br. J. Cancer 103, 1742\u20131748. https:\/\/doi.org\/10.1038\/sj.bjc.6605949 (2010).","journal-title":"Br. J. Cancer"},{"key":"97455_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5365\/WPSAR.2015.6.3.003","volume":"7","author":"AW-C Lin","year":"2016","unstructured":"Lin, A.W.-C. & Wong, K.-H. Surveillance and response of hepatitis B virus in Hong Kong Special Administrative Region, 1988\u20132014. West. Pac. Surveill. Response J. 7, 24\u201328. https:\/\/doi.org\/10.5365\/WPSAR.2015.6.3.003 (2016).","journal-title":"West. Pac. Surveill. Response J."},{"key":"97455_CR38","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1093\/infdis\/jiz038","volume":"219","author":"KSH Liu","year":"2019","unstructured":"Liu, K. S. H. et al. A territorywide prevalence study on blood-borne and enteric viral hepatitis in Hong Kong. J. Infect. Dis. 219, 1924\u20131933. https:\/\/doi.org\/10.1093\/infdis\/jiz038 (2019).","journal-title":"J. Infect. Dis."},{"key":"97455_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3324\/haematol.2018.210252","volume":"104","author":"W Bo","year":"2019","unstructured":"Bo, W., Ghulam, M. & Kosh, A. Reactivation of hepatitis B virus infection in patients with hematologic disorders. Haematologica 104, 435\u2013443. https:\/\/doi.org\/10.3324\/haematol.2018.210252 (2019).","journal-title":"Haematologica"},{"key":"97455_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/jco.2008.18.0182","volume":"27","author":"W Yeo","year":"2009","unstructured":"Yeo, W. et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J. Clin. Oncol. 27, 605\u2013611. https:\/\/doi.org\/10.1200\/jco.2008.18.0182 (2009).","journal-title":"J. Clin. Oncol."},{"key":"97455_CR41","unstructured":"Legislative Council Panel on Health Services Update on Hospital Authority Drug Formulary. https:\/\/www.legco.gov.hk\/yr08-09\/english\/panels\/hs\/papers\/hs0608cb2-1740-4-e.pdf. Accessed on April 1, 2021."},{"key":"97455_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hon.747","volume":"23","author":"DP Cronin","year":"2005","unstructured":"Cronin, D. P. et al. Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin\u2019s lymphoma. Hematol. Oncol. 23, 73\u201381. https:\/\/doi.org\/10.1002\/hon.747 (2005).","journal-title":"Hematol. Oncol."},{"key":"97455_CR43","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/jnci\/dji289","volume":"97","author":"BK Edwards","year":"2005","unstructured":"Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975\u20132002, featuring population-based trends in cancer treatment. J. Natl. Cancer Inst. 97, 1407\u20131427. https:\/\/doi.org\/10.1093\/jnci\/dji289 (2005).","journal-title":"J. Natl. Cancer Inst."},{"key":"97455_CR44","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3109\/10428194.2014.940583","volume":"56","author":"BK Shah","year":"2015","unstructured":"Shah, B. K., Bista, A. & Shafii, B. Disparities in receipt of radiotherapy and survival by age, sex and ethnicity among patients with stage I diffuse large B-cell lymphoma. Leuk. Lymphoma 56, 983\u2013986. https:\/\/doi.org\/10.3109\/10428194.2014.940583 (2015).","journal-title":"Leuk. Lymphoma"},{"key":"97455_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fonc.2016.00101","volume":"6","author":"A Bista","year":"2016","unstructured":"Bista, A., Sharma, S. & Shah, B. K. Disparities in receipt of radiotherapy and survival by age, sex, and ethnicity among patient with stage I follicular lymphoma. Front. Oncol. 6, 101. https:\/\/doi.org\/10.3389\/fonc.2016.00101 (2016).","journal-title":"Front. Oncol."},{"key":"97455_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1200\/jco.2014.58.7543","volume":"33","author":"AJ Olszewski","year":"2015","unstructured":"Olszewski, A. J., Shrestha, R. & Castillo, J. J. Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: Analysis of the National Cancer Data Base. J. Clin. Oncol. 33, 625\u2013633. https:\/\/doi.org\/10.1200\/jco.2014.58.7543 (2015).","journal-title":"J. Clin. Oncol."},{"key":"97455_CR47","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1016\/j.ejca.2006.04.018","volume":"42","author":"DP Cronin-Fenton","year":"2006","unstructured":"Cronin-Fenton, D. P., Sharp, L., Deady, S. & Comber, H. Treatment and survival for non-Hodgkin\u2019s lymphoma: Influence of histological subtype, age, and other factors in a population-based study (1999\u20132001). Eur. J. Cancer 42, 2786\u20132793. https:\/\/doi.org\/10.1016\/j.ejca.2006.04.018 (2006).","journal-title":"Eur. J. Cancer"},{"key":"97455_CR48","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1200\/jco.2009.27.0579","volume":"28","author":"SK Pal","year":"2010","unstructured":"Pal, S. K. & Hurria, A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J. Clin. Oncol. 28, 4086\u20134093. https:\/\/doi.org\/10.1200\/jco.2009.27.0579 (2010).","journal-title":"J. Clin. Oncol."},{"key":"97455_CR49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/gerona\/62.3.275","volume":"62","author":"R Yancik","year":"2007","unstructured":"Yancik, R. et al. Report of the national institute on aging task force on comorbidity. J. Gerontol. A Biol. Sci. Med. Sci. 62, 275\u2013280. https:\/\/doi.org\/10.1093\/gerona\/62.3.275 (2007).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"97455_CR50","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1200\/jco.2004.03.213","volume":"22","author":"GH Lyman","year":"2004","unstructured":"Lyman, G. H., Dale, D. C., Friedberg, J., Crawford, J. & Fisher, R. I. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin\u2019s lymphoma: A nationwide study. J. Clin. Oncol. 22, 4302\u20134311. https:\/\/doi.org\/10.1200\/jco.2004.03.213 (2004).","journal-title":"J. Clin. Oncol."},{"key":"97455_CR51","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/jnci\/86.23.1766","volume":"86","author":"SB Yellen","year":"1994","unstructured":"Yellen, S. B., Cella, D. F. & Leslie, W. T. Age and clinical decision making in oncology patients. J. Natl. Cancer Inst. 86, 1766\u20131770. https:\/\/doi.org\/10.1093\/jnci\/86.23.1766 (1994).","journal-title":"J. Natl. Cancer Inst."},{"key":"97455_CR52","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/00981389.2011.595889","volume":"50","author":"R Glover","year":"2011","unstructured":"Glover, R. et al. Patterns of social support among lymphoma patients considering stem cell transplantation. Soc. Work Health Care 50, 815\u2013827. https:\/\/doi.org\/10.1080\/00981389.2011.595889 (2011).","journal-title":"Soc. Work Health Care"},{"key":"97455_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12911-017-0417-5","volume":"17","author":"D Goldsbury","year":"2017","unstructured":"Goldsbury, D. et al. Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: A validation study. BMC Med. Inform. Decis. Mak. 17, 23. https:\/\/doi.org\/10.1186\/s12911-017-0417-5 (2017).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"97455_CR54","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/jamia\/ocz113","volume":"26","author":"FCG Polubriaginof","year":"2019","unstructured":"Polubriaginof, F. C. G. et al. Challenges with quality of race and ethnicity data in observational databases. J. Am. Med. Inform. Assoc. 26, 730\u2013736. https:\/\/doi.org\/10.1093\/jamia\/ocz113 (2019).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"97455_CR55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12885-018-4187-y","volume":"18","author":"X Bosch","year":"2018","unstructured":"Bosch, X. et al. Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: A retrospective study of a large cohort of major lymphoma subtypes in Spain. BMC Cancer 18, 276. https:\/\/doi.org\/10.1186\/s12885-018-4187-y (2018).","journal-title":"BMC Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97455-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:17:18Z","timestamp":1670080638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97455-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97455"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97455-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17950"}}